Non-Invasive Prenatal Testing - Global Market Outlook (2018-2027)
According to Stratistics MRC, the Global Non-Invasive Prenatal Testing market is accounted for $3.43 billion in 2018 and is expected to reach $11.62 billion by 2027 growing at a CAGR of 14.5% during the forecast period. Some of the key factors such as increasing programs related to awareness and growing maternal period are driving the market growth. However, lack of capable professionals is the restraining factor for the growth of the market.
Non-invasive prenatal testing is as well known as non-invasive parenteral screening, which is a hopeful genetic method of investigative a fetal cell free DNA there in the mothers blood serum for detecting general fetal aneuploidies. Its most important purpose is early recognition of genetic disorders such as trisomy 18 (Edward syndrome), trisomy 21 (Down syndrome), and monosomy X (Turner syndrome). It can as well distinguish the blood group and rhesus actor of the fetus.
By method, down syndrome (Trisomy 21) segment is likely to have a huge demand as it includes positive birth defects, education problems, and facial description. A child with Down syndrome can also contain heart defects and trouble with vision and hearing. According to the centres for illness control and prevention, it is the mostly general chromosomal situation diagnosed in United States. Every year, about six thousands babies born in the United States have Down syndrome. This way that Down syndrome occurs in about one out of each seven hundred babies. On the basis of geography, North America is going to have a lucrative growth during the forecast period due to favourable compensation policies and rise in the occurrence of genetic disorders. This will enlarge the acceptance and command for tests in this region.
Some of the key players in Non-Invasive Prenatal Testing Market include Illumina, Inc , Thermo Fisher Scientific, Inc, GE Healthcare, Perkinelmer Inc, Agilent Technologies, Inc, Beijing Genomics Institute, F. Hoffman-La Roche Ltd., and Laboratory Corporation of America Holdings, Natera, Inc, Yourgene Health, Quest Diagnostics, Sequenom, Bioarray S.L, Berry Genomics and LifeCodexx AG.
• Microdeletion Syndrome
• Turner Syndrome
• Cell-Free DNA in Maternal Plasma Tests
• Biochemical Screening Tests
• Sex Chromosomes Disorders
• Ultrasound Screening
• Fetal Cells in Maternal Blood Tests
• Other Methods
Gestation Periods Covered:
• 25-36 weeks
• 0-12 weeks
• 13-24 weeks
• Low Risk
• High & Average Risk
Test Types Covered:
• Verifi Test
• MaterniT21 PLUS Test
• NIFTY Test
• Harmony Test
• Panorama Test
• Sequenom Test
• IONA Test
• Bambni Test
End Users Covered:
• Diagnostic Laboratories
• Academic and Research Institutes
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.